CURR vs. MXCT, DDI, WLDN, OABI, BWMN, GRVY, NRC, SOHU, OOMA, and IBEX
Should you be buying CURRENC Group stock or one of its competitors? The main competitors of CURRENC Group include MaxCyte (MXCT), DoubleDown Interactive (DDI), Willdan Group (WLDN), OmniAb (OABI), Bowman Consulting Group (BWMN), Gravity (GRVY), National Research (NRC), Sohu.com (SOHU), Ooma (OOMA), and IBEX (IBEX). These companies are all part of the "business services" industry.
CURRENC Group vs.
CURRENC Group (NASDAQ:CURR) and MaxCyte (NASDAQ:MXCT) are both small-cap unclassified companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment.
CURRENC Group has higher earnings, but lower revenue than MaxCyte.
MaxCyte received 11 more outperform votes than CURRENC Group when rated by MarketBeat users.
CURRENC Group has a net margin of 0.00% compared to MaxCyte's net margin of -78.36%. CURRENC Group's return on equity of 0.00% beat MaxCyte's return on equity.
In the previous week, MaxCyte had 4 more articles in the media than CURRENC Group. MarketBeat recorded 6 mentions for MaxCyte and 2 mentions for CURRENC Group. MaxCyte's average media sentiment score of 0.71 beat CURRENC Group's score of -0.25 indicating that MaxCyte is being referred to more favorably in the news media.
MaxCyte has a consensus target price of $9.50, indicating a potential upside of 87.93%. Given MaxCyte's stronger consensus rating and higher possible upside, analysts plainly believe MaxCyte is more favorable than CURRENC Group.
CURRENC Group has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500.
56.0% of CURRENC Group shares are held by institutional investors. Comparatively, 68.8% of MaxCyte shares are held by institutional investors. 43.3% of CURRENC Group shares are held by company insiders. Comparatively, 3.0% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
MaxCyte beats CURRENC Group on 9 of the 13 factors compared between the two stocks.
Get CURRENC Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CURR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CURRENC Group Competitors List
Related Companies and Tools
This page (NASDAQ:CURR) was last updated on 1/21/2025 by MarketBeat.com Staff
